Download SENIOR DIRECTOR OF DEVELOPMENT CARDIOVASCULAR

SENIOR DIRECTOR OF DEVELOPMENT
CARDIOVASCULAR RESEARCH AND INITIATIVES
University of Louisville
Louisville, Kentucky
THE SEARCH
The University of Louisville seeks an effective, creative, and seasoned fundraising professional
to serve as senior director of development, cardiovascular research and initiatives (senior
director) to join the institution at a pivotal time in its history. After completing a record-breaking
$1.1 billion campaign, the university is in the midst of unprecedented growth. Annual
philanthropic support for health sciences has increased steadily and rapidly over the past
several years, reaching $55.7 million in FY2016. The advancement organization is expanding to
meet aggressive growth targets and provide the resources necessary to fuel the university’s
ambitious mission of being a premier, nationally-recognized metropolitan research university.
Reporting to the executive director for health sciences development and a member of his
management team, the senior director will serve as the chief development officer for
cardiovascular research and initiatives. In addition to supervising an assistant director of
development, the senior director will develop innovative strategies to personally cultivate, solicit,
and steward new major gift prospects and will strengthen relationships with existing donors to
secure philanthropic support for program priorities. As such, the senior director will provide
strategic direction and collaborative leadership to maximize major gifts fundraising success in
those areas. The senior director will work closely with Dr. Toni Ganzel, dean of the school of
medicine, key faculty, and other senior advancement leadership.
Ideal candidates will have at least five to seven years of progressively responsible development
experience in a large, highly complex advancement organization, with a preference for
academic medical experience, including a proven track record of leadership, organizational
skills, and success securing six-figure gifts from individuals. In addition, they must have the
personal energy, enthusiasm, and drive to set and achieve ambitious goals as well as the
credibility and emotional maturity to serve as a trusted advisor to faculty and staff. This is an
opportunity to join an exceptional and growing development operation that emphasizes a
collaborative approach and invests in the professional growth and success of its team members.
The University of Louisville has retained the services of Mr. Jack Gorman of Isaacson, Miller,
the national executive search firm, to assist in conducting this search. All inquiries, nominations,
and applications should be directed to Isaacson, Miller and will be held in the strictest
confidence.
UNIVERSITY OF LOUISVILLE
Founded in 1798, the University of Louisville (UofL) is Kentucky’s nationally-recognized,
metropolitan research university. A member of the Kentucky State higher education system,
UofL strives to develop engaged citizens, leaders, and scholars and to improve the quality of life
for local and global communities through teaching, research, and community outreach. Over the
past decade, the institution prioritized research and innovation and enjoyed dramatic growth in
research funding.
UofL offers degrees at the graduate, professional, baccalaureate, and associate levels in more
than 170 fields of study, positioning the university to fulfill its mission to become a premier,
nationally-recognized metropolitan research university. UofL’s 12 schools and colleges include
the following: Arts & Sciences; Business; Dentistry; Education & Human Development;
Engineering; Interdisciplinary and Graduate Studies; Social Work; Law; Medicine; Music;
Nursing; and Public Health & Information Sciences.
Faculty members at UofL are among the top researchers and scholars in their fields. Over the
past two fiscal years, NIH awarded UofL a total of 250 research grants amounting to more than
$105 million. The student-faculty ratio is 17:1; 34.4 percent of classes have fewer than 20
students, facilitating close relationships between students and faculty and enabling students to
do advanced independent work. Of the university’s 2,403 faculty members, 44% are women,
56% are men, and 23% are persons of color.
UofL enrolls more than 22,000 students, approximately 16,000 undergraduates and almost
6,000 graduate students. Overall, they hail from all 50 states and 82 foreign countries, with
about 75 percent from Kentucky.
HEALTH SCIENCES CENTER
The Schools of Medicine, Dentistry, Nursing, and Public Health along with numerous research
centers and institutes comprise the Health Sciences Center, which partners with UofL
Physicians, UofL Dental Associates, UofL Hospital, Jewish Hospital, Norton Hospital, Norton
Children's Hospital, the James Graham Brown Cancer Center and nearly 200 other providers to
form Louisville Medical Center. Collectively, the enterprise is Kentucky’s premier provider of
care and serves more than 500,000 patients a year.
School of Medicine
The school of medicine is the top medical school in Kentucky and has a well-deserved
reputation for medical research. Between 1999 and 2006, the school of medicine experienced
the fastest growth in National Institutes of Health research funding of any medical school in the
nation. Today, world-class researchers are using stem cells to regrow damaged heart muscle,
regenerate damaged spinal cord tissue, and develop new emergency treatments for stroke
patients, to name just a few of the studies being undertaken by faculty in 17 distinct research
centers and institutes.
Today, under the leadership of Dean Toni M. Ganzel, MD, MBA, FACS, the school of medicine
educates some of the nation's finest medical practitioners. It currently enrolls more than 640
students across a wide variety of MD as well as MD/PhD, MD/MPH, and MD/MBA dual degree
Isaacson, Miller
Page 2 of 10
University of Louisville
Senior Director of Development,
Cardiovascular Research and Initiatives
programs. The school of medicine has 852 full-time and 50 part-time faculty and approximately
1,100 staff.
CARDIOVASCULAR RESEARCH
The Centers for Disease Control and Prevention estimates that about 610,000 individuals die of
heart disease in the United States annually, making it the leading cause of death for both men
and women and the largest cost to the healthcare system. In light of these statistics,
cardiovascular research has been identified as the most important area of medical research for
the next decade. Faculty and researchers at UofL school of medicine are dedicated to reversing
the toll of cardiovascular disease through the utilization of a multidisciplinary approach that
encompasses basic, translational, clinical, and population research. UofL clinicians are leaders
in regenerative medicine, growing new cardiac muscle and vasculature to treat damaged
cardiac tissue and in evaluating and assessing the impact of the environment on cardiovascular
health. UofL physicians are at the forefront of cardiothoracic surgery and are internationally
known for advances in heart transplantation, mechanical circulatory support, implantation of
artificial hearts, cell therapy, and environmental cardiology.
Cardiovascular Innovation Institute
Opened in 2007, the Cardiovascular Innovation Institute (CII) is a world-class, state-of-the-art
research facility where faculty and staff are committed to improving lives through
groundbreaking cardiovascular research, scientific discovery, innovative treatments, and new
enterprise creation using some of the world’s most sophisticated technology. CII operates as a
partnership between UofL and the Jewish Heritage Fund for Excellence.
Department of Cardiovascular and Thoracic Surgery
The Department of Cardiovascular and Thoracic Surgery continue to be the leaders in cardiac
assisted devises and clinical excellence, and have made remarkable developments in
laboratory research. Working in state-of-the-art facilities, and using some of the world’s most
sophisticated technology, has enabled our thoracic surgeons to be leaders in diagnosis,
treatment, and discovery of heart disease and other illnesses.
Institute of Molecular Cardiology
In 2001, the University of Louisville established the Institute of Molecular Cardiology (IMC) in
order to facilitate and foster cardiovascular research. Under the direction of Dr. Roberto Bolli,
the Institute has made major contributions in various fields, particularly myocardial
ischemia/reperfusion injury, cardiac regeneration/stem cell therapy, cardioprotection, and
postinfarction LV remodeling and heart failure. The institute is pioneering research to alleviate
the damage caused by heart attacks and regenerate dead muscle with the use of
stem/progenitor cells, and has emerged as a worldwide leader in these areas. The IMC brings
to UofL approximately one-third of all NIH dollars awarded to the University.
Diabetes and Obesity Center
Since its inception in 2008, the Diabetes and Obesity Center has been at the leading edge of
basic and clinical research to generate new knowledge for the prevention of cardiovascular
complications associated with diabetes and obesity. Using a multidisciplinary and collaborative
Isaacson, Miller
Page 3 of 10
University of Louisville
Senior Director of Development,
Cardiovascular Research and Initiatives
approach to research, investigators in the Center are studying how inflammation and changes in
glucose metabolism affect cardiovascular function. The Center has made significant
contributions to understanding the basic mechanisms that contribute to insulin resistance and
how environmental factors and lifestyle choices affect the course and progression of diabetes
and obesity and their impact on cardiovascular health.
UNIVERSITY ADVANCEMENT
UofL’s advancement program exists to build enduring relationships through engagement,
philanthropy, and stewardship to advance the teaching, research, and service mission of the
university. UofL secured $241.9 million in philanthropic support in FY16; of the total, $4.63
million was from annual fund donations, $184 million was from corporate and foundation
support, and $57.8 was from major individual donors. Health Sciences raised $55.7 million in
FY16, significantly more than the $31 million raised in FY15. As of January 30, 2017, UofL
raised $69.3 million and Health Sciences raised $22.2 million toward FY17. As of June 30,
2016, UofL’s endowment was $716 million.
In April 2014, UofL successfully completed the seven-year Charting Our Course Campaign,
raising $1.1 billion and exceeding the original $1 billion goal. Campaign proceeds are being
directed toward scholarships, faculty excellence, research, and new facilities. As part of the
campaign, faculty and staff gave more than $27 million.
University advancement includes alumni relations, annual giving, development, and
advancement services. In total, there are approximately 90 staff members in university
advancement. Employee satisfaction and staff retention have improved dramatically under
current leadership, and the staff also surpasses the national average for diversity. Programs
initiated to support this outstanding team include the Advancement Academy and Grow Our
Own training programs, as well as a robust onboarding program.
SENIOR DIRECTOR OF DEVELOPMENT, CARDIOVASCULAR RESEARCH AND INITIATIVES
The senior director of development, cardiovascular research and initiatives (senior director) is a
member of the health sciences development management team and reports to Ryan Floth,
executive director of health sciences development. The senior director is responsible for
securing private sector support and serves as the chief major gift officer for all cardiovascular
medicine and research initiatives at UofL. In close partnership with the dean of the school of
medicine, key faculty, and senior development leadership, the senior director will leverage
existing philanthropic strengths in cardiovascular research, education, and treatment to expand
the major gift pipeline. The senior director will personally identify, cultivate, solicit, and steward
major gifts primarily from individual donors; grateful patients and their families; and
organizations.
The following are the specific responsibilities and duties of the senior director:

Develop a detailed understanding of the educational, research, and clinical vision of the
school of medicine cardiovascular initiatives.

Provide dynamic leadership for cardiovascular fundraising efforts. Assess the
fundraising potential of cardiovascular initiatives and craft a strategic plan to expand the
major gift pipeline and ensure internal resources are appropriately leveraged.
Isaacson, Miller
Page 4 of 10
University of Louisville
Senior Director of Development,
Cardiovascular Research and Initiatives

Personally manage a portfolio of prospective donors and have direct involvement in the
identification, cultivation, and solicitation of individuals capable of making six-figure gifts
toward cardiovascular research priorities; meet or exceed mutually agreed upon annual
goals.

Define and pursue a comprehensive, effective program of engagement and stewardship
for past, current, and future donors and grateful patients that more closely ties them to
cardiovascular research and creates opportunities for increased giving and engagement;
emphasize cultivation strategies that recognize the importance of donor interest and
motivation in philanthropy and maximize donor potential.

Cultivate, recruit, and train volunteers in support of cardiovascular funding priorities.

Establish and maintain strong, effective relationships with key faculty; collaborate closely
with health sciences development colleagues as well as central and unit-based
advancement colleagues; similarly, build strong, collaborative relationships with
colleagues at partner institutions and facilitate faculty interactions with major national
and local foundations.

Manage and mentor one direct report; lead by example, fostering an environment that
rewards new ideas and risk-taking, builds confidence, encourages team-based efforts,
and promotes diversity; provide necessary structure and guidance to promote a highperforming culture that meets the needs and expectations of a successful,
entrepreneurial, and fast-moving community; utilize existing mechanisms and systems to
define performance expectations, measure staff performance, ensure accountability, and
effectively address performance issues.

Participate in the development of new major initiatives involving philanthropic support or
community interactions.
The senior director can be expected to have the following characteristics and experience:

A deep appreciation for the history, achievements, and aspirations of UofL and the
health sciences center and a genuine passion and energy for contributing to their
success.

At least five to seven years of progressively responsible experience in complex,
successful advancement programs, preferably in an academic medical setting;
meaningful experience in or knowledge of all key areas of development.

Proven ability to effectively cultivate, solicit, and steward individuals capable of making
six-figure gifts.

Professional, collaborative, and accessible leadership style suited to managing in a
complex university setting; uses sound judgment and creatively solves problems in the
face of ambiguity; able to set objectives and performance standards for staff and achieve
fundraising goals.

Goal oriented, ambitious, curious, energetic, and a strong work ethic.
Isaacson, Miller
Page 5 of 10
University of Louisville
Senior Director of Development,
Cardiovascular Research and Initiatives

The credibility, maturity and intellectual depth required to effectively engage and
leverage faculty and researchers in the cultivation, solicitation, and stewardship of key
prospects and donors.

Strong understanding of data and analytics; data-driven decision maker; naturally
curious and able to recognize connections and opportunities.

Superior communication skills; excellent listening skills; able to effectively translate
academic, technical, and research information for all audiences; clear, crisp, and
compelling written and oral communication.

A high degree of integrity and character; a sense of humor, a humble approach, and an
outgoing, optimistic personality.

Knowledge of HIPAA as it relates to development activities.

Ability to travel and attend evening and weekend events as necessary.

Undergraduate degree required.
TO APPLY
This search is being led by Jack Gorman and Rachel Ellenport with Jean Jacoby and Sam Zurn.
For more information, to make a nomination, or to apply for this role, please visit:
www.imsearch.com/5971
The University of Louisville is an Affirmative Action, Equal Opportunity, Americans with Disabilities
Employer, committed to diversity, and in that spirit, seek s applications from a broad variety of candidates.
Isaacson, Miller
Page 6 of 10
University of Louisville
Senior Director of Development,
Cardiovascular Research and Initiatives
ADDENDUM: LEADERSHIP
Toni Ganzel, MD, MBA, FACS
Dean
School of Medicine
University of Louisville
Toni M. Ganzel became dean of the UofL school of medicine in April 2013, after serving as interim
dean since May 2012. At UofL school of medicine since 1983, prior to bec oming interim dean,
Ganzel served as associate dean of student affairs from 2001-2003 and senior associate dean for
students and academic affairs from 2003.
Ganzel’s first role at the school of medicine was as an assistant professor of otolaryngology,
advancing to associate and then full professor in 1998. She served as division and program director
of otolaryngology from 1993–2001 and was also chief of otolaryngology at Kosair Children’s Hospital
from 1989–2002. Ganzel came to UofL from Creighton University, where she was assistant
professor of surgery from 1982-1983.
Ganzel is a Harvard Macy Educational fellow and a fellow of the Executive Leadership in Academic
Medicine (ELAM) Program for Women at Drexel University College of Medicine in Philadelphia.
ELAM is the nation’s only in-depth program that develops the professional and personal skills
required to lead and manage in today's complex health care environment, with special attention to
the unique challenges facing women in leadership positions.
Ganzel earned her bachelor of science and medical degrees from the University of Nebraska and
completed her residency in otolaryngology at the University of Nebraska Medical Center. She
earned a master’s degree in business administration/medical group management from the University
of St. Thomas in Minneapolis.
Laman A. Gray, Jr., MD
Executive and Medical Director
Cardiovascular Innovation Institute
University of Louisville
Laman Gray, Jr. oversees CII’s clinical translation program as its medical director. Gray’s vision to
promote translational research by unifying basic science and clinical practice was the foundation for
the Cardiovascular Innovation Institute. Throughout his distinguish ed career as a cardiothoracic
surgeon, Gray has been a pioneer in the field of cardiovascular assist devices and artificial organ
transplantation.
Gray is an internationally recognized leader in the fields of artificial hearts and circulatory support
systems. He performed the first heart transplant in Kentucky in 1984. In 2001, his surgical team
implanted the first fully implantable replacement heart, the AbioCor™.
Gray served as director of University of Louisville School of Medicine’s Thoracic and Cardi ovascular
division for over 33 years. In 2008, he was awarded the University of Kentucky Medallion for
Intellectual Achievement, which recognizes high intellectual achievement by Kentuckians.
Gray earned his medical degree from John Hopkins University in Baltimore, MD. He completed his
training with an internship and residencies in general and thoracic surgery at the University of
Michigan.
Isaacson, Miller
Page 7 of 10
University of Louisville
Senior Director of Development,
Cardiovascular Research and Initiatives
Jesse Roman, MD, FACP, FAACP
Chair, Department of Medicine
School of Medicine
University of Louisville
Jesse Roman has been the chair of the department of medicine since 2009. He is chief of the
division of pulmonary, critical care & sleep disorders medicine, as well as professor of medicine,
pharmacology and toxicology. Prior to coming to UofL, Roman served as director of Emory’s
division of pulmonary, allergy and critical care medicine; director of the Emory center for respiratory
health; and the director for research for the Emory interstitial lung disease program.
The UofL’s department of medicine is one of the premier academic programs in the country. The
department encompasses two accredited internal medicine training programs (internal medicine
residency and med-peds residency) as well as post-doctoral clinical and research fellowships in 10
subspecialties, including cardiovascular medicine. The research program rivals the most innovative
centers in the country. Its programs include world-class research in stem cell biology, nutrition,
hepatology, respiratory disorders like acute lung injury and fibrosis, pneumonia and N1H1 infection,
diabetes, renal disease, and cancer.
Roman earned his medical degree from the University of Puerto Rico. He completed his residency at
the San Juan Veterans Affairs Medical Center and fellowship at Washington University. His clinical
expertise is interstitial lung disease, pulmonary fibrosis, and sarcoidosis.
Roberto Bolli, MD, FAHA
Scientific Director
Cardiovascular Innovation Institute
University of Louisville
Roberto Bolli is director of the division of cardiovascular medicine and UofL’s institute for molecular
cardiology and the scientific director of the Cardiovascular Innovation Institute. He is also
department executive vice chairman and vice chair for r esearch in the department of medicine.
His research focuses on preventing the damage caused during heart attacks by studying ischemic
preconditioning, the phenomenon in which heart muscle exposed to brief periods of stress becomes
resistant to the tissue death that might be caused by a heart attack. Recently, he has pioneered the
fields of stem cell therapy and regenerative cardiology.
He is investigating the use of adult cardiac stem cells to repair dead heart tissue, pioneering the use
of stem cells taken from the patient for potential heart repair applications.
Bolli is the recipient of numerous awards and honors, including the Basic Research Prize of the
American Heart Association (AHA) (2001), the MERIT Award from the NIH (2001), the Research
Achievement Award from the International Society for Heart Research (ISHR) (2004), the Lucian
Award from McGill University (2004), the Ken Bowman Award from the University of Manitoba, and
the Howard Morgan Award from the International Academy of Cardiovascular Sciences , the Harris
Distinguished Scientist Award from the ISHR (2015), the Shottenstein Prize from the Ohio State
University (2015), the Research Achievement Award of the AHA (2013), the Medal of Merit of the
ISHR (2013), the Distinguished Scientist Award from the AHA (2008), and the Cannon Award and
Wiggers Award from the American Physiological Society (2011). He has published more than 420
peer-reviewed articles.
Isaacson, Miller
Page 8 of 10
University of Louisville
Senior Director of Development,
Cardiovascular Research and Initiatives
Bolli received his medical degree from the University of Perugia, Italy. He completed a research
Fellowship at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD and a clinical
fellowship in Cardiology at Baylor College of Medicine.
Mark S. Slaughter, MD
Professor/Chair, Department of Cardiovascular and Thoracic Surgery
School of Medicine
University of Louisville
In addition to Mark Slaughter being the Chair of the Department of Cardiovascular and Thoracic
Surgery, he is the director of the Heart Transplant and Mechanical Assist Device program at Jewish
Hospital & St. Mary’s HealthCare. He is an internationally acclaimed expert in heart transplants and
ventricular assist devises (VAD).
After receiving his medical degree from the Indiana University School of Medicine, Slaughter
completed his general surgery residency at McGaw Medical Center of Northwestern University in
Chicago, and his cardiovascular and thoracic surgery fellowship at the University of Minnesota
Hospital and Clinic.
Prior to leaving Chicago’s Advocate Christ Medical Center and the University of Illinois in 2008,
Slaughter implanted over 250 ventricular assist devices and was a leader in destination therapy, or
permanent use of the device for patients who aren’t transplant eligible. His work has also focused on
using the VAD as a bridge to transplant, as well as for myocardial recovery and rescue surgeries.
Slaughter’s overlying goal is to offer individuals with heart failure an alternative to heart
transplantation, repairing hearts and helping them recover naturally, without the need of a transplant.
Keith Inman
Vice President for University Advancement
University of Louisville
Keith Inman has served as UofL vice president for university advancement since November 2006.
Throughout his tenure, Inman has focused on strategically building a modern, meaningful
organization that helps fulfill UofL’s critical mission. He oversees development, alumni/annual fund,
and advancement services functions. Inman leads a development office that annually raises more
than $200 million. He personally raises $20-40 million each year. Inman launched the successful
Charting Our Course fundraising campaign in 2007; the campaign ended in 2014, exceeding the $1
billion dollar goal ahead of schedule and by nearly $59 million. Over the duration of the campaign,
fundraising increased by an unprecedented 165 percent.
Prior to joining UofL, Inman held prominent positions with Jewish Hospital & St. Mary's HealthCare
(JHSMH). In 2005, Inman served as senior vice president of external relations and executive director
for the Jewish Hospital & St. Mary's HealthCare Foundation. In this role, he was responsible for
public relations, advertising, community relations, and foundation operations. During 2004 and 2005,
Inman served as interim administrative director of the Cardiovascular Innovation Institute. This
partnership generated more than $52 million in support fr om federal, state, UofL, Jewish Hospital,
and local funding sources. Earlier, Inman served as executive director of the Jewish Hospital
Foundation and vice president of JHSMH.
Inman was with UofL prior to his tenure at JHSMH, serving as assistant vice p resident of the UofL
Health Science Center development office starting in 1998. In this capacity he functioned as the
chief development officer for the medical, nursing, dental and allied health schools.
Isaacson, Miller
Page 9 of 10
University of Louisville
Senior Director of Development,
Cardiovascular Research and Initiatives
Earlier career roles included serving as executive director and president of the Jim Valvano
Foundation for Cancer Research, created by ESPN and the family of Jim Valvano, in Cary, NC and
serving as associate athletic director for advancement at the University of Maryland in 1992.
Inman earned a bachelor’s degree from UofL.
Bryan Robinson
Senior Assistant Vice President for Development
University of Louisville
Bryan Robinson has eleven years of fundraising and development experience and is currently in his
second tenure at UofL. Robinson reports to the vice president for university advancement and is
responsible for day-to-day operations on the health sciences campus, while also managing the
interim executive director for the Belknap campus. Robinson returned to UofL after leaving Indiana
University (Bloomington) in 2013 to assist with the completion of the $1 billion Charting our Course
capital campaign. Robinson personally closes millions of dollars in gifts each year and has received
the "Goal Setter" award for goal achievement and attainment each fiscal year that he has worked at
the University of Louisville during two separate tenures.
Robinson holds a bachelor of science in pre-law studies and a master’s degree in leadership in
higher education from UofL; he is currently a doctoral candidate at Be llarmine University, expecting
to defend his PhD dissertation in early 2017 after having researched rural poverty for four years.
Isaacson, Miller
Page 10 of 10
University of Louisville
Senior Director of Development,
Cardiovascular Research and Initiatives